Home Authors Posts by Ariel Jones

Ariel Jones

142 POSTS 0 COMMENTS

Evaluating Pirtobrutinib in Patients with Previously Treated Mantle Cell Lymphoma

Restrictive Opioid Prescribing Protocol for Cancer Patients Reduces Opioid Prescriptions Following Surgery

Evaluating Fixed-Duration Ibrutinib and Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia

Rituximab, Bendamustine, and Bortezomib Combination Improves Responses in Relapsed/Refractory Waldenström Macroglobulinemia

Belantamab Mafodotin Shows ‘Encouraging Results’ in Patients with Relapsed/Refractory Multiple Myeloma

CANTATA – Addition of a Glutaminase Inhibitor to Cabozantinib Fails to Improve Survival in Renal Cell Carcinoma

Orelabrutinib Shows Favorable Safety and Efficacy in Relapsed/Refractory Waldenström Macroglobulinemia

GLOW: MRD Outcomes After Fixed-Duration Ibrutinib Combinations in Older CLL Patients

iStopMM: Screening for MGUS Enables Earlier Detection and Intervention

Long-Term Follow-up From GRIFFIN Confirms Durability of Daratumumab Responses in Transplant-Eligible...

Liso-cel Versus Standard of Care as Second-Line Therapy for Relapsed/Refractory LBCL

Anti-BCMA CAR T-Cell Therapy CT103A Provides Rapid, Durable Responses

123...15Page 1 of 15